Drug testing for MDMA (ecstasy)
MDMA, or 3, 4-methylene-dioxymethamphetamine, is a Schedule I drug and can produce feelings of euphoria, emotional warmth, decreased anxiety and hallucinogenic effects. The Drug Enforcement Administration (DEA) describes MDMA as a drug which acts as a stimulant and psychedelic, producing an energizing effect, distortions in time and perception and enhanced enjoyment of tactile experiences. Long-term physical effects of MDMA use include irritability, trouble sleeping, anxiety and addiction according to the National Institute on Drug Abuse.
MDMA, also called Ecstasy, has a reputation for being a “club drug” distributed in tablet form with logos and brand names for users to seek out. Other drugs similar to MDMA, such as MDA, 3, 4-methylene-dioxyamphetamine, or PMA, are often sold as Ecstasy, which can lead to overdose and death when the user takes additional doses to obtain the desired effect. Today, a high percentage of pills contain other drugs; some pills marketed as Ecstasy may not even contain any MDMA according to the Center for Substance Abuse Research (CESAR). Historically, MDMA was the active ingredient in “Molly.” However, more recently, Molly has been found to contain synthetic stimulants such as Methylone, MDPV, and 4-MEC to name a few.
Employers can screen applicants and employees to help to deter drug use and keep their workplaces drug-free.
View the Quest Diagnostics Drug Testing Index™ for positivity and trends in workplace drug testing.